Partner Mauricio Uribe authored, “NDAs Remain a Potent Business Tool,” which was published in MedTech Intelligence.
Excerpt: “Nondisclosure Agreements (NDAs) are one of the core legal documents that most, if not all, startup companies should have available. NDAs are typically concise in nature and may be assumed to be a simple agreement. However, in our experience, NDAs are quite versatile in nature and should be considered for a number of different use scenarios encountered by a medtech startup. These use scenarios can be classified as “external” or “internal” in nature.”
